Risks of therapy-related hematologic neoplasms beyond myelodysplastic syndromes and acute myeloid leukemia. Dores GM, Linet MS, Curtis RE, Morton LM, et al. Blood 2022 Nov 15. pii: 493239. doi: 10.1182/blood.2022018051.

Read + Share

Amedeo Smart

Independent Medical Education

Dores GM, Linet MS, Curtis RE, Morton LM, et al. Risks of therapy-related hematologic neoplasms beyond myelodysplastic syndromes and acute myeloid leukemia. Blood 2022 Nov 15. pii: 493239. doi: 10.1182/blood.2022018051.
PMID: 36379026